HLB Life Science CO.,LTD.
Develops anti-cancer drugs and manufactures in vitro diagnostic medical devices.
067630 | KO
Overview
Corporate Details
- ISIN(s):
- KR7067630004
- LEI:
- Country:
- South Korea
- Address:
- 경기도 화성시 동탄첨단산업1로 51-9 8층(영천동,엠타워지식산업센터), 화성시
- Website:
- https://www.hlb-lsmc.com/
- Sector:
- Manufacturing
Description
HLB Life Science is a specialized pharmaceutical and biotechnology firm focused on the development of innovative anti-cancer medications and the manufacturing of medical devices. The company's research and development efforts center on targeted therapies and cell therapies for oncology. In parallel, it develops, manufactures, and distributes in vitro diagnostic (IVD) medical devices and quasi-drugs. The company's portfolio also includes the clinical development of anti-cancer drugs for animals, aiming to provide comprehensive solutions across human and animal health.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-10-04 00:00 |
전환가액의조정
|
Korean | 10.1 KB | ||
| 2022-10-04 00:00 |
[기재정정]전환가액의조정
|
Korean | 16.0 KB | ||
| 2022-10-04 00:00 |
합병등종료보고서(합병)
|
Korean | 19.2 KB | ||
| 2022-08-24 00:00 |
기타경영사항(자율공시)(소규모합병 승인 이사회결의(주주총회 갈음) 결과 보고)
|
Korean | 7.7 KB | ||
| 2022-08-12 00:00 |
주권관련사채권의취득결정
|
Korean | 35.0 KB | ||
| 2022-08-12 00:00 |
반기보고서 (2022.06)
|
Korean | 1.6 MB | ||
| 2022-07-29 00:00 |
투자판단관련주요경영사항(제3상 가교 임상시험계획(IND) 신청)
|
Korean | 16.2 KB | ||
| 2022-07-18 00:00 |
주요사항보고서(회사합병결정)
|
Korean | 59.6 KB | ||
| 2022-07-18 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.4 KB | ||
| 2022-07-18 00:00 |
회사합병결정(종속회사의주요경영사항)
|
Korean | 16.3 KB | ||
| 2022-07-18 00:00 |
회사합병결정(종속회사의주요경영사항)
|
Korean | 16.7 KB | ||
| 2022-07-01 00:00 |
증권발행결과(자율공시)
|
Korean | 6.0 KB | ||
| 2022-06-29 00:00 |
기타경영사항(자율공시)(신주인수권 행사가액 조정 조건 오기 정정)
|
Korean | 11.4 KB | ||
| 2022-06-29 00:00 |
[기재정정]주요사항보고서(타법인주식및출자증권양수결정)
|
Korean | 45.1 KB | ||
| 2022-06-29 00:00 |
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 78.6 KB |
Automate Your Workflow. Get a real-time feed of all HLB Life Science CO.,LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for HLB Life Science CO.,LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HLB Life Science CO.,LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
